Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth
CXCR7 is an atypical chemokine receptor that recruits β-arrestin (ARRB2) and internalizes into clathrin-coated intracellular vesicles where the complex acts as a scaffold for cytoplasmic kinase assembly and signal transduction. Here, we report that CXCR7 was elevated in the majority of prostate canc...
Main Authors: | Galina Gritsina, Ka-wing Fong, Xiaodong Lu, Zhuoyuan Lin, Wanqing Xie, Shivani Agarwal, Dong Lin, Gary E. Schiltz, Himisha Beltran, Eva Corey, Colm Morrissey, Yuzhuo Wang, Jonathan C. Zhao, Maha Hussain, Jindan Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-08-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI166248 |
Similar Items
-
Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
by: Ala Litman-Zawadzka, et al.
Published: (2020-08-01) -
The many faces of neuroendocrine differentiation in prostate cancer progression
by: Stephane eTerry, et al.
Published: (2014-03-01) -
CXCR3 chemokine receptor ligands in sarcoidosis
by: N. M. Lazareva, et al.
Published: (2021-03-01) -
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
by: Irina Chifu, et al.
Published: (2020-11-01) -
Chemokine Receptors, CXCR1 and CXCR2, Differentially Regulate Exosome Release in Hepatocytes.
by: Hiroyuki Nojima, et al.
Published: (2016-01-01)